{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:44:52Z","timestamp":1792683892569,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.puhe.2023.11.023","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T10:48:15Z","timestamp":1702291695000},"page":"199-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study"],"prefix":"10.1016","volume":"226","author":[{"given":"Z.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-704X","authenticated-orcid":false,"given":"G.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.puhe.2023.11.023_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"issue":"10091","key":"10.1016\/j.puhe.2023.11.023_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.puhe.2023.11.023_bib3","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.puhe.2023.11.023_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.2093","article-title":"Association of occupational pesticide exposure with immunochemotherapy response and survival among patients with diffuse large B-cell lymphoma","volume":"2","author":"Lamure","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.puhe.2023.11.023_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/10428190500420973","article-title":"Environmental factors and childhood acute leukemias and lymphomas","volume":"47","author":"Mcnally","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.puhe.2023.11.023_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/aje\/kwp018","article-title":"Positive associations between ionizing radiation and lymphoma mortality among men","volume":"169","author":"Richardson","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.puhe.2023.11.023_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fonc.2019.00300","article-title":"Environmental and other extrinsic risk factors contributing to the pathogenesis of Cutaneous T cell lymphoma (CTCL)","volume":"9","author":"Ghazawi","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.puhe.2023.11.023_bib8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/ijc.33369","article-title":"Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: an exposome-wide analysis","volume":"148","author":"Saberi Hosnijeh","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.puhe.2023.11.023_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/hon.2725","article-title":"Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute","volume":"38","author":"Parra","year":"2020","journal-title":"Hematol Oncol"},{"issue":"9","key":"10.1016\/j.puhe.2023.11.023_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/bjc.2011.357","article-title":"Age, gender, and racial differences in incidence and survival in primary CNS lymphoma","volume":"105","author":"Villano","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.puhe.2023.11.023_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","article-title":"Lymphoma","volume":"43","author":"Mugnaini","year":"2016","journal-title":"Prim Care"},{"issue":"3","key":"10.1016\/j.puhe.2023.11.023_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0000000000000451","article-title":"Lymphoma classification","volume":"26","author":"de Leval","year":"2020","journal-title":"Cancer J"},{"issue":"3","key":"10.1016\/j.puhe.2023.11.023_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","article-title":"Enigmatic sex disparities in cancer incidence","volume":"27","author":"Edgren","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.puhe.2023.11.023_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.26744","article-title":"Sex differences in lymphoma incidence and mortality by subtype: a population-based study","volume":"98","author":"Radkiewicz","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/07853890.2022.2039957","article-title":"Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017","volume":"54","author":"Sun","year":"2022","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.puhe.2023.11.023_bib18","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.puhe.2023.11.023_bib19","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41375-019-0612-8","article-title":"How we use venetoclax with hypomethylating agents\u00a0for the treatment of newly diagnosed patients with acute myeloid leukemia","volume":"33","author":"Jonas","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib20","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","article-title":"Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study","volume":"54","author":"Zhang","year":"2022","journal-title":"Ann Med"},{"issue":"10258","key":"10.1016\/j.puhe.2023.11.023_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.puhe.2023.11.023_bib22","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.18632\/aging.204006","article-title":"Burden of lymphoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019","volume":"14","author":"Liu","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.puhe.2023.11.023_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.puhe.2023.11.023_bib24","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jmv.27538","article-title":"The global disease burden of varicella-zoster virus infection from 1990 to 2019","volume":"94","author":"Huang","year":"2022","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21147\/j.issn.1000-9604.2021.01.02","article-title":"Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from Global Burden of Disease Study","volume":"33","author":"Zhang","year":"2021","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10654-011-9636-8","article-title":"Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005","volume":"27","author":"Gao","year":"2012","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.puhe.2023.11.023_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0022034520908533","article-title":"Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: a systematic analysis for the global burden of disease 2017 study","volume":"99","author":"Bernabe","year":"2020","journal-title":"J\u00a0Dent Res"},{"issue":"1","key":"10.1016\/j.puhe.2023.11.023_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang","year":"2022","journal-title":"J\u00a0Hematol Oncol"},{"issue":"6","key":"10.1016\/j.puhe.2023.11.023_bib29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1055-9965.EPI-11-0038","article-title":"Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation","volume":"20","author":"Clarke","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.puhe.2023.11.023_bib30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00247-019-04529-8","article-title":"Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma","volume":"49","author":"McCarten","year":"2019","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.puhe.2023.11.023_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.12.029","article-title":"Targeted inhibitors and antibody immunotherapies: novel therapies for paediatric leukaemia and lymphoma","volume":"164","author":"Brivio","year":"2022","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.puhe.2023.11.023_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2019000847","article-title":"The immune landscape and response to immune checkpoint blockade therapy in lymphoma","volume":"135","author":"Kline","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.puhe.2023.11.023_bib33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/07357900801975280","article-title":"Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature","volume":"26","author":"Ragin","year":"2008","journal-title":"Cancer Invest"},{"issue":"2","key":"10.1016\/j.puhe.2023.11.023_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11904-014-0199-7","article-title":"Review of HIV in the Caribbean: significant progress and outstanding challenges","volume":"11","author":"Figueroa","year":"2014","journal-title":"Curr HIV AIDS Rep"},{"issue":"3","key":"10.1016\/j.puhe.2023.11.023_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/geronb\/gbab055","article-title":"Aging in East Asia: new findings on retirement, health, and well-being","volume":"77","author":"Yeung","year":"2022","journal-title":"J\u00a0Gerontol B Psychol Sci Soc Sci"},{"issue":"6","key":"10.1016\/j.puhe.2023.11.023_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.puhe.2023.11.023_bib37","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era","volume":"28","author":"Ziepert","year":"2010","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350623004535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350623004535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:44:21Z","timestamp":1758501861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350623004535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"alternative-id":["S0033350623004535"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2023.11.023","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2023.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}